Fact.MR – A Market Research and Competitive Intelligence Provider: According to the latest Fact.MR analysis, endovascular stent market is driven by rising prevalence of aneurysm disease, as well as cardiac problems among the ageing population forward throughout the forecast period.
Application of Endovascular Stent for Abdominal Aortic Aneurysm to Witness Rapid Growth
Fact.MR’s latest report on endovascular stent market offers unbiased industry analysis for the period between 2020 and 2030. The study divulges exclusive information about existing opportunities and emerging trends across leading segments in terms of product, usage and end user. It also highlights various strategies employed by key manufacturers to gain edge in the market.
Fact.MR – A Market Research and Competitive Intelligence Provider: According to the latest Fact.MR analysis, endovascular stent market is driven by rising prevalence of aneurysm disease, as well as cardiac problems among the ageing population forward throughout the forecast period. The rising prevalence of diseases such as cardiovascular illnesses, aortic aneurysms, and artery disease, as well as a preference for minimally invasive surgical techniques, has fueled the endovascular stent industry.
Furthermore, increased incidence of cardiovascular diseases has been attributed to superior lifestyle choices such as alcohol use, smoking, and poor diet habits of an individual, which is expected to boost the endovascular stent market throughout the forecast period.
The American Heart Association estimates that the United States will have more than 48% of cardiovascular patients in 2019. Furthermore, according to CDC data, more than 6,00,000 individuals died in the United States each year in 2015 due to a rise in the prevalence of abdominal aortic aneurysm (AAA), which was the leading cause of death.
For Critical Insights On This Market, Request For More Info
https://www.factmr.com/connectus/sample?flag=B&rep_id=5262
An endovascular stent is a fabric tube that is grafted during endovascular surgery to treat aneurysms with minimally invasive surgical procedures. The demand for endovascular stents is increasing due to technical advancements in the medical industry, which have shifted from open procedures to endovascular surgeries.
Due to rising prevalence of cardiovascular problems, the worldwide endovascular stent market is expected to develop significantly over the forecast period. The endovascular aneurysm repair (EVAR) stent segment holds the highest share, owing to technical advancements in surgical instruments, which predicted an increasing demand for EVAR stents. Additionally, endovascular aneurysm repair (EVAR) stent market is expected to witness rapid growth in the future.
The COVID-19 epidemic has had a number of negative effects on the world economy, including a shortage of care units and ventilation sites, a labor shortage, scarcity of raw materials, and a halt in transportation. The commercial issues surrounding the disruption of medical device production are expected to have a short-term detrimental impact on the global market. Reduced hospital visits and surgery rescheduling as a result of the COVID-19 epidemic are also predicted to slow the endovascular stent market’s short-term growth throughout the forecast period.
Key Takeaways from Endovascular Stent Market Survey
- North America is expected to lead the endovascular stent market due to rising prevalence of cardiovascular disease and availability of reimbursement.
- Due to the growing frequency of abdominal aortic aneurysm incidence, the abdominal aortic aneurysm (AAA) segment dominated the market by application.
- By product, endovascular aneurysm repair (EVAR) stent segment to dominate the market on the back of rapid technological advancements.
Key Drivers
- The rising frequency of aneurysm disease, as well as cardiac problems among the ageing population, are likely to boost the endovascular stent market.
Key Restraints
- During the forecast period, the high cost of treatment and related problems are projected to limit the growth of the endovascular stent market.
Ask Your Endovascular Stent Market Related Questions & Get Customized Report
https://www.factmr.com/connectus/sample?flag=RC&rep_id=5262
Competitive Landscape
Some of the prominent players operating in the endovascular stent market profiled by Fact.MR are:
- Abbott Laboratories
- Boston Scientific Co.
- Medtronic plc
- Cardinal Health, Inc.
- B. Braun Melsungen AG
- Biotronik Se & Co.
- Cook Medical, Inc.
- Terumo Co.
- Microport Scientific Co.
- Meril Life Sciences Pvt Ltd.
More Insights on the Endovascular Stent Sales Outlook
Fact.MR provides an unbiased analysis of endovascular stent market, presenting forecast statistics for the period from 2020-2030. The study divulges compelling insights on the global demand for endovascular stent with a detailed segmentation on the basis of:
Product Type:
- Endovascular aneurysm repair (EVAR) stent
- Fenestrated EVAR
- Aortic stents
- Thoracic aortic aneurysm graft stents
Application:
- Thoracic Aortic Aneurysm
- Abdominal aortic aneurysm (AAA)
End-User:
- Hospitals & Cardiovascular centers
- Ambulatory Surgical Centers
- Others
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle-East & Africa (MEA)
Key Questions Covered in the Endovascular Stent Market Outlook Report
- The report offers insight into endovascular stent demand outlook for 2020-2030
- The market study also highlights projected sales growth for endovascular stent market between 2020 and 2030
- Endovascular stent market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
- Endovascular stent market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others
Explore Fact.MR’s Coverage on the Healthcare Domain –
Dual Therapy Stent Market Analysis- The risk of heart disease has increased as a result of daily stress, excessive blood pressure, and a lack of knowledge about health. Furthermore, people’s reliance on fast and instant meals has exacerbated the problem of rising cholesterol levels. The global rate of heart attacks has increased as a result of a fast-paced lifestyle. The growing population necessitates the use of more dual therapy stents in hospitals. In hospitals, clinics, and outpatient surgeries, dual therapy stents are employed. Because the patient’s life is at jeopardy, dual therapy stents are frequently used without hesitation. Additionally, as it treats patients with complicated lesions and atherosclerotic burden, the dual therapy stents market is expected to grow.
Arterial Stents Market Forecast- The rising prevalence of cardiovascular disorders has pushed people to seek treatment sooner rather than later in order to extend their lives. According to the American Heart Association (AHA), coronary heart disease is the leading cause of death among all cardiovascular diseases. The rising prevalence of cardiovascular disorders has prompted people to seek out novel therapeutic options. The need for minimally invasive surgical techniques has increased as a result. In this case, stents are the recommended approach of repairing heart abnormalities. This is due to the fact that stents inhibit restenosis. Therefore, the arterial stents market is poised to expand impressively.
Carotid Stenting Systems Market Insights- The key driver for the growth of the global carotid stenting systems market is the rising incidence of cardiac diseases such as atherosclerosis and coronary artery diseases, which is fueled by rising risk factors such as high cholesterol intake, sedentary lifestyles, substance abuse, diabetes, obesity, and high blood pressure. The global carotid stenting systems market is being driven by technological advancements in stents such as drug eluting stents, the use of biodegradable and bio-absorbable materials for stent production, and advances in stent design such as bifurcated stents, among others.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000’s trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR